Oncology Biosimilars Market Size, Share & Trend | Industry Analysis Report, 2025

1
Oncology Biosimilars Market
Oncology Biosimilars Market Segmentation by Drug
Class - G-CSF, Monoclonal Antibodies, and
Hematopoietic Agents Disease Indication - Breast
Cancer, Non-small Cell Lung Cancer, Colorectal
Cancer, Neutropenia, and Blood Cancer (Leukemia
and Non-Hodgkin Lymphoma) and Distribution
Channel - Hospital Pharmacy, Retail Pharmacy, and
Online Pharmacy), Forecast 2017 - 2025
2019 Transparency Market Research, All Rights
Reserved
2
Table of Content
Sr. No. Content
Chapter 1 Preface
Chapter 2 Assumptions and Research Methodology
Chapter 3 Executive Summary Global Oncology Biosimilars Market
Chapter 4 Market Overview
Chapter 5 Porters Five Force Analysis
Chapter 6 Market Dynamics
Chapter 7 Global Oncology Biosimilars Market Analysis and Forecasts, By Drug Class
Chapter 8 Global Oncology Biosimilars Market Analysis and Forecasts, By Disease Indication
Chapter 9 Global Oncology Biosimilars Market Analysis and Forecasts, By Distribution Channel
Chapter 10 Global Oncology Biosimilars Market Analysis and Forecasts, By Region
Chapter 11 North America Oncology Biosimilars Market Analysis and Forecast
Chapter 12 Europe Oncology Biosimilars Market Analysis and Forecast
Chapter 13 Asia Pacific Oncology Biosimilars Market Analysis and Forecast
Chapter 14 Rest of the World Oncology Biosimilars Market Analysis and Forecast
Chapter 15 Competition Landscape
2019 Transparency Market Research, All Rights
Reserved
3

Empty Capsules Market - Snapshot

• The global oncology biosimilars market is
  predicted to benefit immensely with the rising
  demand for affordable therapies for cancer.
• Pharmaceutical companies worldwide are
  hard-focused on developing biosimilars and
  generic medicines to combat cancer at all stages
  and also for the treatment of the disease.
• Oncology biosimilars are similar versions of
  oncology biologics that are manufactured by
  different companies and have been officially
  approved for cancer treatment.

2019 Transparency Market Research, All Rights
Reserved
4
(No Transcript)
5
Report Highlights

• The global oncology biosimilars market to expand
  at an outstanding 27.5 CAGR between 2017 and
  2025, for the market to become worth US17,478.2
  mn by the end of 2025.
• The report studies the global oncology
  biosimilars market based on a few parameters.
• The segments into which the oncology biosimilars
  market is divided depending upon drug class are
  G-CSF, monoclonal antibody, and hematopoietic
  agents.

Request For Sample
2019 Transparency Market Research, All Rights
Reserved
6
Continue..

• Rising Initiatives to Meet Up Demand for
  Inexpensive Cancer Therapies to Drive Growth
• Efforts of Key Players to Widen Their Offerings
  and Patent Expiration to Boost Growth
• Leading companies in the global oncology
  biosimilars market that are profiled in this
  report are Celltrion Inc., Biocon, Dr. Reddys
  Laboratories Ltd., STADA Arzneimittel AG.

Request For Brochure
2019 Transparency Market Research, All Rights
Reserved
7
Contact
To know more about us, please visit our website
www.transparencymarketresearch.com For sales
queries or new topics email us on
sales_at_transparencymarketresearch.com
Thank You
2019 Transparency Market Research, All Rights
Reserved